China National Accord Medicines (SZSE:000028) Accumulated Depreciation: ¥0 Mil (As of Mar. 2026)


SZSE:000028 China National Accord Medicines Corp Ltd SZSE:000028
78 GF Score
Price ¥19.90
GF Value ¥25.04
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China National Accord Medicines Accumulated Depreciation?

China National Accord Medicines SZSE:000028 -2.45% 78 Accumulated Depreciation is ¥0 Mil as of Mar. 2026. GuruFocus rates SZSE:000028 with a GF Score™ of 78/100 and a GF Value™ of ¥25.04 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

China National Accord Medicines's quarterly accumulated depreciation increased from Sep. 2025 (¥0 Mil) to Dec. 2025 (¥-1,436 Mil) but then stayed the same from Dec. 2025 (¥-1,436 Mil) to Mar. 2026 (¥0 Mil).

China National Accord Medicines's annual accumulated depreciation increased from Dec. 2023 (¥-1,169 Mil) to Dec. 2024 (¥-1,334 Mil) and increased from Dec. 2024 (¥-1,334 Mil) to Dec. 2025 (¥-1,436 Mil).

China National Accord Medicines Accumulated Depreciation Related Terms

China National Accord Medicines Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for China National Accord Medicines's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines Accumulated Depreciation Chart

China National Accord Medicines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -884.42 -1,019.46 -1,169.26 -1,333.81 -1,436.48

China National Accord Medicines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1,399.42 0.00 -1,436.48 0.00
SZSE:000028
78GF Score
China National Accord Medicines Corp Ltd SZSE:000028
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China National Accord Medicines Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of ¥0 Mil mean?
China National Accord Medicines (SZSE:000028) has a Accumulated Depreciation of ¥0 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on China National Accord Medicines and its competitors.
Is China National Accord Medicines' Accumulated Depreciation too high?
China National Accord Medicines' current Accumulated Depreciation is ¥0 Mil. Overall, China National Accord Medicines has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Accord Medicines' Accumulated Depreciation compare to MCK and COR?
China National Accord Medicines' Accumulated Depreciation of ¥0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Distribution company?
A good Accumulated Depreciation depends on the Medical Distribution industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on China National Accord Medicines and its competitors. China National Accord Medicines's current Accumulated Depreciation is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Accord Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Accord Medicines (SZSE:000028) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥25.04, compared to a current price of ¥19.90 — trading 20.5% below its estimated fair value. The current Accumulated Depreciation is ¥0 Mil. China National Accord Medicines' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For China National Accord Medicines (SZSE:000028), the current Accumulated Depreciation is ¥0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China National Accord Medicines (SZSE:000028) Overvalued in 2026?

Based on GuruFocus' analysis, China National Accord Medicines stock appears to be undervalued. The current stock price of ¥19.90 is trading 20.5% below its estimated GF Value™ of ¥25.04. GuruFocus considers China National Accord Medicines to be Modestly Undervalued.

Key valuation signals for SZSE:000028:

  • Accumulated Depreciation: ¥0 Mil
  • GF Value™: ¥25.04 vs. price of ¥19.90 (20.5% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the SZSE:000028 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China National Accord Medicines Business Description

Other Exchanges 200028:China
Address No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
78GF Score

Get the complete analysis for SZSE:000028

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.90
Price
¥25.04
GF Value